Matsuzuka F, Miyauchi A, Katayama S, Narabayashi I, Ikeda H, Kuma K, Sugawara M
Kuma Hospital, Kobe, Japan.
Thyroid. 1993 Summer;3(2):93-9. doi: 10.1089/thy.1993.3.93.
We describe the clinical aspects of primary thyroid lymphoma, particularly diagnostic procedures and successful therapy based on our observation of 119 patients with primary thyroid lymphoma. Thyroid lymphoma occurred exclusively in the thyroid gland of patients with Hashimoto's thyroiditis as a rapidly growing mass in the thyroid gland. Therefore, progressively enlarging goiter and compression symptoms were the most common clinical manifestations. A significant number of patients in our series had subclinical hypothyroidism (14%) or overt hypothyroidism (27%) because of the coexistence of Hashimoto's thyroiditis. Whenever thyroid lymphoma is suspected, we recommend an ultrasound scan of the thyroid gland and fine needle aspiration biopsy as initial diagnostic procedures. Thyroid ultrasound showed characteristic asymmetrical pseudocystic pattern in 43 of the 46 patients (93%), and thyroid cytologic examination showed abundant monomorphic infiltration of lymphoid cells. Among 83 patients who underwent fine needle aspiration biopsy, 65 patients (78.3%) were diagnosed correctly and 10 patients (12%) had borderline cytologic results. Thus, 90% of patients with thyroid lymphoma were diagnosed or the diagnosis suspected based on fine needle aspiration biopsy. To confirm the diagnosis of lymphoma histologically and to determine the degree of malignancy, open biopsy taking 2-3 g tissue should be done for all cases. Treatment of thyroid lymphoma does not require resection of all lymphoma tissue or total thyroidectomy. Our successful treatment is radiation therapy combined with six courses of CHOP chemotherapy (cyclophosphamide, adriamycin, vincristine, prednisolone). This mode of therapy improved the 8-year survival rate to nearly 100% regardless of the histological type of malignancy.
我们描述了原发性甲状腺淋巴瘤的临床情况,特别是基于对119例原发性甲状腺淋巴瘤患者的观察所得出的诊断方法和成功的治疗方案。甲状腺淋巴瘤仅发生于患有桥本甲状腺炎患者的甲状腺内,表现为甲状腺内快速生长的肿块。因此,甲状腺进行性肿大和压迫症状是最常见的临床表现。由于合并桥本甲状腺炎,我们系列研究中的大量患者存在亚临床甲状腺功能减退(14%)或显性甲状腺功能减退(27%)。每当怀疑有甲状腺淋巴瘤时,我们建议将甲状腺超声扫描和细针穿刺活检作为初步诊断方法。46例患者中有43例(93%)甲状腺超声显示特征性的不对称假囊肿模式,甲状腺细胞学检查显示淋巴细胞大量单形性浸润。在83例行细针穿刺活检的患者中,65例(78.3%)被正确诊断,10例(12%)细胞学结果处于临界状态。因此,90%的甲状腺淋巴瘤患者通过细针穿刺活检得以确诊或疑似诊断。为从组织学上确诊淋巴瘤并确定恶性程度,所有病例均应进行开放活检,取2 - 3克组织。甲状腺淋巴瘤的治疗并不需要切除所有淋巴瘤组织或全甲状腺切除术。我们成功的治疗方法是放射治疗联合六个疗程的CHOP化疗(环磷酰胺、阿霉素、长春新碱、泼尼松龙)。无论恶性肿瘤的组织学类型如何,这种治疗方式将8年生存率提高到了近100%。